Study highlights potential of p-tau217 assays in Alzheimer’s clinical trials and diagnosis Post author: Post published:March 14, 2024 Post category:uncategorized The performance of two commercial phospho-tau217 (p-tau217) assays. You Might Also Like Telehealth shows promise for substance use disorder treatment in rural areas February 12, 2025 New research sheds light on IL-23’s role in chronic inflammatory bowel diseases June 12, 2024 Fatty acid inhibitor plus chemo could improve treatment efficacy for breast cancer patients with brain metastases July 30, 2024
Fatty acid inhibitor plus chemo could improve treatment efficacy for breast cancer patients with brain metastases July 30, 2024